SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-060823
Filing Date
2012-11-09
Accepted
2012-11-09 15:42:22
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v325678_10q.htm 10-Q 676871
2 EXHIBIT 31.1 v325678_ex31-1.htm EX-31.1 9928
3 EXHIBIT 31.2 v325678_ex31-2.htm EX-31.2 9881
4 EXHIBIT 32.1 v325678_ex32-1.htm EX-32.1 3859
5 EXHIBIT 32.2 v325678_ex32-2.htm EX-32.2 3707
  Complete submission text file 0001144204-12-060823.txt   9546178

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scmp-20120930.xml EX-101.INS 1991738
7 XBRL TAXONOMY EXTENSION SCHEMA scmp-20120930.xsd EX-101.SCH 44220
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scmp-20120930_cal.xml EX-101.CAL 66654
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scmp-20120930_def.xml EX-101.DEF 192790
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scmp-20120930_lab.xml EX-101.LAB 398598
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scmp-20120930_pre.xml EX-101.PRE 350422
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 121193487
SIC: 2834 Pharmaceutical Preparations